SPT Labtech and Semarion Join Forces to Advance Automated Cell-Based Assays

SPT Labtech, a global leader in laboratory automation, has announced a new collaboration with Semarion, a University of Cambridge spin-out focused on microcarrier technology for cell biology. The partnership will combine SPT Labtech’s firefly® liquid handling platform with Semarion’s SemaCyte® microcarriers to develop flexible, miniaturized, and automated workflows for cell-based assays.

Cell-based assays play a critical role in drug discovery and biological research, but their automation and miniaturization have remained challenging. By integrating SPT Labtech’s adaptable liquid handling system with Semarion’s microcarrier technology, the two companies aim to simplify and speed up key steps in adherent cell assay development, including applications like high-content imaging and cell painting.

Maryia Karpiyevich, Product Development Scientist at SPT Labtech, said, “This collaboration gives us the chance to bring together innovative microcarrier technology and flexible automation in one platform. Our goal is to provide scientists with better tools to advance cellular research.”

Jeroen Verheyen, CEO and Co-Founder of Semarion, added, “Partnering with SPT Labtech allows us to combine our microcarrier technology with their automation expertise. This opens the door to new, streamlined workflows that are both miniaturized and scalable, helping researchers develop assays more efficiently.”

Morten Frost, Chief Commercial Officer at SPT Labtech, commented, “We’re committed to supporting technologies that make lab work easier and more adaptable. This partnership reflects that commitment, offering solutions that can scale and adjust as research demands change.”

The companies will work together on application protocols, proof-of-concept studies, and workflow optimization to deliver practical, automated solutions for cell-based research.